Company / Revenue
Zimmer Biomet Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$8.2B
FY2025
5-year range
$6.8B / $8.2B
FY2021-FY2025
Trend
+7.2%
vs FY2024
Sector context
#31 of 156
Health Care
What the data says
Zimmer Biomet's revenue of $8.2B is higher than 80% of companies in the Health Care sector (FY2025). Revenue has increased for 5 consecutive years, from $6.1B in FY2020 to $8.2B in FY2025.
Based on SEC 10-K filings.
$8.2B in FY2025 with a 5-year CAGR of +6.1%. Top quartile in the Health Care sector.
Improved from $7.4B to $8.2B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +5.9%
- 5-Year CAGR
- +6.1%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 156This company $8.2B Sector average $19.0B
▼
-56.7% below sector average
Key checks
Key Insights
- Zimmer Biomet's revenue has grown for 5 consecutive years.
- 5-year CAGR of +6.1%, indicating consistent growth.
- In FY2025, revenue increased 7.2% year-over-year.
- Ranks #31 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.2B | +7.2% |
| FY2024 | $7.7B | +3.8% |
| FY2023 | $7.4B | +6.5% |
| FY2022 | $6.9B | +1.6% |
| FY2021 | $6.8B | +11.4% |
| FY2020 | $6.1B | -21.5% |
| FY2019 | $7.8B | +1.8% |
| FY2018 | $7.7B | -1.7% |
| FY2017 | $7.8B | +67.0% |
| FY2016 | $4.7B | -22.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026